Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane alone versus sevoflurane plus nebulized lidocaine in endoscopic sinus surgery
PACTR202511907079054Phase 4Not yet recruiting
- Sponsor
- Marwan Ahmed farouq ahmed
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sevoflurane and lidocaine in chronic rhinosinusitis (CRS) (2 arms), sponsored by Marwan Ahmed farouq ahmed. Primary endpoint: Total intraoperative blood loss in surgical field during endoscopic sinus surgery. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
sevofluranelidocaine
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on PACTR202511907079054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511907079054.